Tubulozole-induced G2/M cell cycle arrest in human colon cancer cells through formation of microtubule polymerization mediated by ERKI/2 and Chk1 kinase activation

被引:20
作者
Chou, Yean-Hwei
Ho, Yuan-Soon
Wu, Chi-Chen
Chai, Chiah-Yang
Chen, Soul-Chin
Lee, Chia-Hwa
Tsai, Pei-Shan
Wu, Chih-Hsiung
机构
[1] Taipei Med Univ, Sch Med, Div Gen Surg, Dept Surg, Taipei 110, Taiwan
[2] Taipei Med Hosp, Taipei 110, Taiwan
[3] Taipei Med Univ, Grad Inst Biomed Technol, Taipei, Taiwan
[4] Taipei Med Univ, Sch Med, Dept Anesthesiol, Taipei, Taiwan
[5] Taipei Med Hosp, Taipei, Taiwan
关键词
tubulozole; Chk1; colon cancer; G2/M arrest; ERK1/2;
D O I
10.1016/j.fct.2007.01.012
中图分类号
TS2 [食品工业];
学科分类号
0832 [食品科学与工程];
摘要
Our studies demonstrated that human colon cancer cells (COLO 205), with higher expression level of check point kinase 1 (Chk1), were more sensitive to microtubule damage agent Tubulozole (TUBU) induced G2/M phase arrest than normal human colon epithelia] (CRL) cells. TUBU (10 mu M, for 3 h) treatment resulted in rapid and sustained phosphorylation of Cdc25C (Ser-216) leading to increased 14-3-3 beta binding. This resulted in increased nuclear translocation. In addition, TUBU induced phosphorylation of the Cdc25C (Ser-216) and Bad (Ser-155) proteins were blocked by Chk1 SiRNA-transfection. Surprisingly, cellular apotosis was observed in cells treated with TUBU after Chk1 SiRNA inhibition. We further demonstrated that extracellular signal-regulated kinase (ERK) activation by TUBU was needed for Chk1 kinase activation and microtubule formation as shown by the attenuation of these responses by the ERK 1/2 specific inhibitor PD98059. However, TUBU induced ERK1/2 phosphorylation was not blocked in the Chk1 SiRNA-transfected COLO 205 cells. These results imply that ERK1/2 mediated Chk1 activation may be play an important role in determining TUBU induced G2/M arrest or apoptosis in COLO 205 cells. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1356 / 1367
页数:12
相关论文
共 90 条
[1]
The disappearance of cyclins A and B and the increase in activity of the G2/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the α22/US1.5 and UL13 viral genes [J].
Advani, SJ ;
Brandimarti, R ;
Weichselbaum, RR ;
Roizman, B .
JOURNAL OF VIROLOGY, 2000, 74 (01) :8-15
[2]
Ahamed S, 2001, MOL CARCINOGEN, V30, P88, DOI 10.1002/1098-2744(200102)30:2&lt
[3]
88::AID-MC1017&gt
[4]
3.0.CO
[5]
2-E
[6]
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53 [J].
Bacus, SS ;
Gudkov, AV ;
Lowe, M ;
Lyass, L ;
Yung, Y ;
Komarov, AP ;
Keyomarsi, K ;
Yarden, Y ;
Seger, R .
ONCOGENE, 2001, 20 (02) :147-155
[7]
The broad-range cyclin-dependent kinase inhibitor UCN-01 induces apoptosis in colon carcinoma cells through transcriptional suppression of the Bcl-xL protein [J].
Bhonde, MR ;
Hanski, ML ;
Magrini, R ;
Moorthy, D ;
Müller, A ;
Sausville, EA ;
Kohno, K ;
Wiegand, P ;
Daniel, PT ;
Zeitz, M ;
Hanski, C .
ONCOGENE, 2005, 24 (01) :148-156
[8]
ABNORMAL STRUCTURE AND EXPRESSION OF P53 GENE IN HUMAN HEPATOCELLULAR-CARCINOMA [J].
BRESSAC, B ;
GALVIN, KM ;
LIANG, TJ ;
ISSELBACHER, KJ ;
WANDS, JR ;
OZTURK, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1973-1977
[9]
Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer [J].
Cappel, WHDN ;
Meulenbeld, HJ ;
Kleibeuker, JH ;
Nagengast, FM ;
Menko, FH ;
Griffioen, G ;
Cats, A ;
Morreau, H ;
Gelderblom, H ;
Vasen, HFA .
INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (03) :468-471
[10]
Castellano S, 2000, ARCH PHARM, V333, P373, DOI 10.1002/1521-4184(200011)333:11<373::AID-ARDP373>3.0.CO